Emergent Biosolutions reported $403.8M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 94.64M 172.32M
Akebia Therapeutics AKBA:US $ 207.2M 39.79M
ALKERMES ALKS:US $ 310.44M 52.1M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Amarin AMRN:US $ 222.88M 104.14M
Ani Pharmaceuticals ANIP:US $ 15.25M 9.01M
Biomarin Pharmaceutical BMRN:US $ 617.14M 24.39M
Chimerix CMRX:US $ 26.17M 0.73M
Coherus Biosciences CHRS:US $ 360.54M 30.8M
Emergent Biosolutions EBS:US $ 403.8M 43.7M
Exact Sciences EXAS:US $ 273.78M 89.94M
Exelixis EXEL:US $ 567.33M 74.86M
Flexion Therapeutics FLXN:US $ 136.82M 29.2M
Glaxosmithkline GSK:US $ 3453M 50M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Immunogen IMGN:US $ 245.76M 6.22M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
IONIS PHARMACEUT IONS:US $ 1987M 1421.88M
Ironwood Pharmaceuticals IRWD:US $ 574.28M 81.58M
Jazz Pharmaceuticals JAZZ:US 1000 0
Lexicon Pharmaceuticals LXRX:US $ 120.92M 31.03M
Lonza Group LONN:SW 501M 6M
Moderna Inc MRNA:US 5.55B 53M
Myriad Genetics MYGN:US $ 295.2M 176.8M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Opko Health OPK:US $ 148.6M 82.84M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Ptc Therapeutics PTCT:US $ 189.82M 12.47M
Sarepta Therapeutics SRPT:US $ 1599.11M 98.16M
Seattle Genetics SGEN:US $ 685.17M 271.74M
Teva Pharmaceutical Industries TEVA:US $ 2045M 391M
United Therapeutics UTHR:US $ 908.5M 33.7M
Vanda Pharmaceuticals VNDA:US $ 50.52M 6.72M